Civic Intelligence

Foundation Fighting Blindness Clinical Research Institute

990 • Fiscal year 2021 • EIN 45-0524687

Jul 01, 2020 to Jun 30, 2021 • Filed on Nov 11, 2021

6925 Oakland Mills Road No 701Columbia, MD 21045

(410) 423-0600

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

15th percentile

0.01x

Higher debt load relative to assets than 15% of similar nonprofits.

2021 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2021

Liabilities / Revenue

10th percentile

0.02x

Higher debt load relative to revenue than 10% of similar nonprofits.

2021 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2021

Net Margin

98th percentile

90%

Higher net margin than 98% of similar nonprofits.

2021 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2021

Top Officer Pay

87th percentile

$570,691

Higher top officer pay than 87% of similar nonprofits.

Top officer pay equals 2.7% of source-year revenue.

2021 filings • 501(c)3 • $25M-$50M nonprofits • Source year 2021

Asset Growth

98th percentile

171%

Faster asset growth than 98% of similar nonprofits.

2021 filings • 501(c)3 • $25M-$50M nonprofits • Annualized from 2020 to 2021

Revenue Growth

86th percentile

78%

Faster revenue growth than 86% of similar nonprofits.

2021 filings • 501(c)3 • $25M-$50M nonprofits • Annualized from 2020 to 2021

Assets

Up

$31,011,511

Up $19,572,854 (+171%) from 2020

Net Assets

Up

$30,604,571

Up $20,293,794 (+197%) from 2020

Liabilities

Down

$406,940

Down $720,940 (-64%) from 2020

Revenue

Up

$21,228,882

Up $9,289,793 (+78%) from 2020

Expenses

Down

$2,021,967

Down $962,435 (-32%) from 2020

Net Income

Up

$19,206,915

Up $10,252,228 (+114%) from 2020

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$60M$40M$20M$0Assets 2011: $2,381,367Liabilities 2011: $1,152,805Net Assets 2011: $1,228,5622011Assets 2012: $1,766,098Liabilities 2012: $1,310,177Net Assets 2012: $455,9212012Assets 2013: $2,308,427Liabilities 2013: $1,752,099Net Assets 2013: $556,3282013Assets 2014: $2,940,657Liabilities 2014: $2,782,681Net Assets 2014: $157,9762014Assets 2015: $1,333,743Liabilities 2015: $1,109,829Net Assets 2015: $223,9142015Assets 2016: $2,709,507Liabilities 2016: $1,621,320Net Assets 2016: $1,088,1872016Assets 2017: $4,864,479Liabilities 2017: $3,107,750Net Assets 2017: $1,756,7292017Assets 2018: $3,894,860Liabilities 2018: $681,174Net Assets 2018: $3,213,6862018Assets 2019: $4,037,044Liabilities 2019: $398,800Net Assets 2019: $3,638,2442019Assets 2020: $11,438,657Liabilities 2020: $1,127,880Net Assets 2020: $10,310,7772020Assets 2021: $31,011,511Liabilities 2021: $406,940Net Assets 2021: $30,604,5712021Assets 2022: $45,350,093Liabilities 2022: $416,512Net Assets 2022: $44,933,5812022Assets 2023: $47,303,067Liabilities 2023: $65,457Net Assets 2023: $47,237,6102023Assets 2024: $52,460,807Liabilities 2024: $85,288Net Assets 2024: $52,375,5192024Assets 2025: $59,633,698Liabilities 2025: $103,316Net Assets 2025: $59,530,3822025

Highlighted filing

2021

Assets$31,011,511
Liabilities$406,940
Net Assets$30,604,571

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$30M$20M$10M$0-$10MExpenses 2011: $3,160,3042011Revenue 2012: $2,870,275Expenses 2012: $3,642,916Net Income 2012: -$772,6412012Revenue 2013: $5,195,870Expenses 2013: $5,093,512Net Income 2013: $102,3582013Revenue 2014: $4,737,262Expenses 2014: $5,135,614Net Income 2014: -$398,3522014Revenue 2015: $4,672,253Expenses 2015: $4,606,315Net Income 2015: $65,9382015Revenue 2016: $3,694,149Expenses 2016: $3,491,183Net Income 2016: $202,9662016Revenue 2017: $5,414,179Expenses 2017: $4,800,240Net Income 2017: $613,9392017Revenue 2018: $13,259,129Expenses 2018: $11,809,240Net Income 2018: $1,449,8892018Revenue 2019: $3,077,860Expenses 2019: $3,063,769Net Income 2019: $14,0912019Revenue 2020: $11,939,089Expenses 2020: $2,984,402Net Income 2020: $8,954,6872020Revenue 2021: $21,228,882Expenses 2021: $2,021,967Net Income 2021: $19,206,9152021Revenue 2022: $15,424,974Expenses 2022: $1,051,912Net Income 2022: $14,373,0622022Revenue 2023: $9,316,837Expenses 2023: $1,014,874Net Income 2023: $8,301,9632023Revenue 2024: $8,751,135Expenses 2024: $1,309,685Net Income 2024: $7,441,4502024Revenue 2025: $7,006,271Expenses 2025: $2,441,051Net Income 2025: $4,565,2202025

Highlighted filing

2021

Revenue$21,228,882
Expenses$2,021,967
Net Income$19,206,915
Jump To
Filing Snapshot
Filing Period
Jul 1, 2020 to Jun 30, 2021
Signed
Nov 11, 2021
Return Version
2020v4.1
Gross Receipts
$24,228,841
Mission and Program Overview

Mission

The foundation fighting blindness clinical research institute's mission is to accelerate the translation of retinal laboratory-based research into clinical trials to expedite the commercialization of patient therapies.

The foundation fighting blindness retinal degeneration fund's mission is to accelerate the translation of retinal laboratory-based research into clinical trials to expedite the commercialization of patient therapies.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments Program Related$11,038,170$21,506,962▲ $10,468,792
Cash and Non-Interest-Bearing Accounts$267,991$1,791,845▲ $1,523,854
Accounts Receivable$129,912$1,604,137▲ $1,474,225
Pledges and Grants Receivable-$5,000-
Prepaid Expenses and Deferred Charges$2,584$1,757▼ $827
Total Assets$11,438,657$31,011,511▲ $19,572,854
Other Assets Total$0$6,101,810▲ $6,101,810
Liabilities
Grants Payable$750,000--
Other Liabilities$351,055$351,056▲ $1
Accounts Payable and Accrued Expenses$26,825$55,884▲ $29,059
Total Liabilities$1,127,880$406,940▼ $720,940
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$10,310,777$30,604,571▲ $20,293,794
Total Net Assets Fund Balance$10,310,777$30,604,571▲ $20,293,794
Total Liabilities and Net Assets / Fund Balance$11,438,657$31,011,511▲ $19,572,854

Asset Categories

AssetBook ValueDepreciationBasis
Investment Program Related Org$457,140--
Other Assets Org$500,000--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Russell W KellyVP, Investments & AllianceFT$205,125$70,216$275,341
Benjamin R YerxaCEO/pres (ex-officio)PT$145,638$54,104$199,742
Jason D MenzoCOO-$16,387$5,311$21,698
Nancy DavenportVP, Finance-$16,865$3,031$19,896

Board Members and Trustees

NameTitle
Warren ThalerChairman
Adrienne Graves PhdDirector
Eugene De Juan MdDirector
Kelly LisbakkenDirector
David BrintEx Officio Director
Jacque Duncan MdEx Officio Director
Jonathan Steinberg MdEx Officio Director
Revenue and Support

Revenue Composition

Contributions and Grants
$11,140,788
Program Service Revenue
$27,500
Investment Income
$10,060,594
Other Revenue
$0
Change in Net Assets
$19,206,915

Audited Revenue Reconciliation

Revenue per Audited Statements
$10,057,594
Revenue Not Reported on Financial Statements
$11,171,288
Revenue Not Reported on Form 990
$30,759,491
Other Revenue Adjustments
$11,171,288
Total Revenue per Audited Statements
$40,817,085
Total Revenue per Form 990
$21,228,882
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$1,000,000
Salaries, Compensation, and Employee Benefits$849,141
Other Expenses$172,826
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Foreign Grants$1,000,000--$1,000,000
Current Officers, Directors, Trustees, and Key Employees$583,466$100,000-$683,466
Other Salaries and Wages$62,514--$62,514
Fees for Services Legal$58,492$2,088-$60,580
Fees for Services Management$14,330$39,138-$53,468
Other Employee Benefits$48,155--$48,155
Payroll Taxes$28,462$3,312-$31,774
Pension Plan Contributions$23,232--$23,232
Occupancy$14,731--$14,731
Fees for Services Accounting-$4,500-$4,500
Other Expenses$3,765$319-$4,084
Office Expenses$2,134--$2,134
Conferences and Meetings$1,524--$1,524
All Other Expenses$415$890-$1,305
Total Functional Expenses$1,850,370$171,597$0$2,021,967

Audited Expense Reconciliation

Line ItemAmount
Expenses Not Reported on Form 990$40,742,591
Total Expenses per Audited Statements$31,593,270
Expenses Not Reported on Financial Statements$11,171,288
Other Expense Adjustments$11,171,288
Total Expenses per Form 990$2,021,967
Expenses per Audited Statements$-9,149,321
International Activity

International Summary

Offices
0
Employees
0
Spending
$8,815,949

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
Yes
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
Yes

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland)Investment-00$7,815,949
Europe (including Iceland & Greenland)Grantmaking-00$1,000,000
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Due to Related Party$351,056
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 6

The sole member of ffb rd fund is the foundation fighting blindness, inc. (ffb).

Form 990, Part VI, Section A, Line 7A

Ffb elects the directors of ffb rd fund annually as needed.

Form 990, Part VI, Section B, Line 11B

Data to prepare the federal form 990 is provided to our outside accounting firm for preparation and guidance. After it has been completed, a draft of the federal form 990 is reviewed by the controller and chief business officer. With the cbo's approval, the draft federal form 990 is then made available to all board members. A final draft is made available to all board members before filing.

Form 990, Part VI, Section B, Line 12C

In connection with any actual or possible conflict of interest, an interested person (including officers, directors, and key employees) must disclose, in writing prior to any discussion or vote upon a proposal, the existence and nature of his or her personal interest to the chair of the board and chair of the board committee considering the proposed transaction or arrangement. After disclosure of the financial interest and all material facts, the interested person shall leave the board or committee meeting while the financial interest is discussed and voted upon. The remaining board shall decide if a conflict of interest exists, and if so, whether there is a compelling reason to recommend to the board that the conflict of interest policy be overridden. A quorum is needed for voting and the vote to override shall be by majority and duly noted in the minutes.

Form 990, Part VI, Section C, Line 19

Ffb rd fund's federal form 990 tax return and consolidated audit are available at its supported organization's website, www.fightingblindness.org. Other public governing documents including the conflict of interest policy are available upon request through the contact information disclosed on ffb's web site. These documents are available for the same period of disclosure as set forth in section 6104(d).

FORM 990, PART VII, SECTION A:

The foundation fighting blindness, inc. (ffb), a related organization, acts as the common paymaster for ffb rd fund. Ffb also approves and reviews any compensation to officers, directors, trustees and key employees of ffb rd fund in conformance with their compensation determination policy.

Filing and Contact Details

Filer

Filer Name
Foundation Fighting Blindness
EIN
45-0524687
Phone
4104230600
Address
6925 OAKLAND MILLS ROAD NO 701, COLUMBIA, MD 21045

Signing Officer

Name
Peter Ginsberg
Title
Evp/chief Business Officer
Phone
4104230600
Signed
2021-11-11
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Benjamin Yerxa
Formed
2003
Legal Domicile
De
Voting Board Members
7
Independent Board Members
7
Employees
6
Volunteers
10

Preparer

Firm
Rsm US Llp
Address
100 INTERNATIONAL DRIVE SUITE 1400, BALTIMORE, MD 21202
Preparer
Julia Flannery CPA
Phone
4102469301
Supplemental Narrative

Additional Explanations

FORM 990, PART XI, LINE 9:

Gain on equity method investment 1,086,879.

Financial Statement Notes

PART X, LINE 2:

The foundation performed an evaluation of its uncertainty in income tax for the years ended june 30, 2021 and 2020, and determined that there were no matters that would require recognition in the consolidated financial statements or that may have any effect on its tax-exempt status. The foundation follows the accounting standard on accounting for uncertainty in income taxes, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. Under this policy, the foundation may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position would be sustained on examination by taxing authorities, based on the technical merits of the position. Management has evaluated the foundation's tax positions and has concluded that the foundation has taken no uncertain tax positions that require adjustment to the financial statements to comply with provisions of this guidance. The foundation is no longer subject to income tax examinations for the u.s. Federal, state or local tax authorities for years before june 30, 2018.

PART XI, LINE 2D - OTHER ADJUSTMENTS:

Revenue from affiliate included on consolidated financial statements 29,476,390. Gain on equity method investments 1,086,879.

PART XI, LINE 4B - OTHER ADJUSTMENTS:

Elimination entry included on financial statements 11,171,288.

PART XII, LINE 2D - OTHER ADJUSTMENTS:

Expenses from affiliates included on consolidated financial statements 40,546,369.

PART XII, LINE 4B - OTHER ADJUSTMENTS:

Elimination entry included on financial statements 11,171,288.

Raw XML AppendixShowing 400 of 675 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt026825
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt055884
IRS990/AccountsReceivableGrp/BOYAmt0129912
IRS990/AccountsReceivableGrp/EOYAmt01604137
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0THE FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND'S MISSION IS TO ACCELERATE THE TRANSLATION OF RETINAL LABORATORY-BASED RESEARCH INTO CLINICAL TRIALS TO EXPEDITE THE COMMERCIALIZATION OF PATIENT THERAPIES.
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt0890
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0415
IRS990/AllOtherExpensesGrp/TotalAmt01305
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0PETER GINSBERG
IRS990/BooksInCareOfDetail/PhoneNum04104230600
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt06925 OAKLAND MILLS ROAD NO 701
IRS990/BooksInCareOfDetail/USAddress/CityNm0COLUMBIA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd021045
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0267991
IRS990/CashNonInterestBearingGrp/EOYAmt01791845
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0100000
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0583466
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0683466
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt01524
IRS990/ConferencesMeetingsGrp/TotalAmt01524
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt011140788
IRS990/CYGrantsAndSimilarPaidAmt01000000
IRS990/CYInvestmentIncomeAmt010060594
IRS990/CYOtherExpensesAmt0172826
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt027500
IRS990/CYRevenuesLessExpensesAmt019206915
IRS990/CYSalariesCompEmpBnftPaidAmt0849141
IRS990/CYTotalExpensesAmt02021967
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt021228882
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0THE THREE LARGEST PROGRAM SERVICES ACCOMPLISHMENTS (AS MEASURED BY EXPENSES) FOR THE FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND (FFB-RDF) DURING FISCAL 2021 WERE EQUITY INVESTMENTS IN ATSENA THERAPEUTICS, SPARINGVISION SAS, AND VEDERE BIO II. ATSENA THERAPEUTICS IS A CLINICAL-STAGE COMPANY, SPARINGVISION IS A LATE-STAGE PRECLINICAL COMPANY, AND VEDERE BIO II IS IN EARLY-STAGE PRECLINICAL COMPANY, WITH EACH ADVANCING PROMISING THERAPIES FOR RETINAL DEGENERATIVE DISEASES. FISCAL 2021 SUMMARY:FFB-RDF INVESTED AN ADDITIONAL $4,249,996 IN ATSENA THERAPEUTICS TO HELP SUPPORT A CLINICAL-STAGED\ GENE THERAPY PROGRAM FOR THE TREATMENT OF LCA1 AND TWO PRECLINICAL PROGRAMS FOR THE TREATMENT OF X-LINKED RETINOSCHISIS AND USHER1B.FFB-RDF INVESTED AN ADDITIONAL $3,023,036 IN SPARINGVISION SAS TO HELP ADVANCE A LATE PRECLINICAL GENE AGNOSTIC GENE THERAPY PROGRAM FOR THE TREATMENT OF MULTIPLE TYPES OF RETINAL DEGENERATIVE DISEASE INCLUDING RETINITIS PIGMENTOSA. FFB-RDF INVESTED $3,358,877 IN VEDERE BIO II TO SUPPORT THE EARLY PRECLINICAL MILESTONES TO ADVANCE A GENE-AGNOSTIC THERAPEUTIC CANDIDATE FOR MULTIPLE TYPES OF RETINAL DEGENERATIVE DISEASE INCLUDING RETINITIS PIGMENTOSA.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt06
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01850370
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt04500
IRS990/FeesForServicesAccountingGrp/TotalAmt04500
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt02088
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt058492
IRS990/FeesForServicesLegalGrp/TotalAmt060580
IRS990/FeesForServicesManagementGrp/ManagementAndGeneralAmt039138
IRS990/FeesForServicesManagementGrp/ProgramServicesAmt014330
IRS990/FeesForServicesManagementGrp/TotalAmt053468
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt01000000
IRS990/ForeignGrantsGrp/TotalAmt01000000
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt010.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt426.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt538.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt636.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt714.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt82.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt104.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt752808
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt857117
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt949753
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1012346
IRS990/Form990PartVIISectionAGrp/PersonNm0DAVID BRINT
IRS990/Form990PartVIISectionAGrp/PersonNm1WARREN THALER
IRS990/Form990PartVIISectionAGrp/PersonNm2EUGENE DE JUAN MD
IRS990/Form990PartVIISectionAGrp/PersonNm3ADRIENNE GRAVES PHD
IRS990/Form990PartVIISectionAGrp/PersonNm4KELLY LISBAKKEN
IRS990/Form990PartVIISectionAGrp/PersonNm5JACQUE DUNCAN MD
IRS990/Form990PartVIISectionAGrp/PersonNm6JONATHAN STEINBERG MD
IRS990/Form990PartVIISectionAGrp/PersonNm7BENJAMIN R YERXA
IRS990/Form990PartVIISectionAGrp/PersonNm8JASON D MENZO
IRS990/Form990PartVIISectionAGrp/PersonNm9RUSSELL W KELLY
IRS990/Form990PartVIISectionAGrp/PersonNm10NANCY DAVENPORT
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt7181259
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt818842
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt9225588
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt1018662
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt7336624
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt8357995
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10167955
IRS990/Form990PartVIISectionAGrp/TitleTxt0EX OFFICIO DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1CHAIRMAN
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5EX OFFICIO DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6EX OFFICIO DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7CEO/PRES (EX-OFFICIO)
IRS990/Form990PartVIISectionAGrp/TitleTxt8COO
IRS990/Form990PartVIISectionAGrp/TitleTxt9VP, INVESTMENTS & ALLIANCE
IRS990/Form990PartVIISectionAGrp/TitleTxt10VP, FINANCE
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02003
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt010060594
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantAmt01000000
IRS990/GrantsPayableGrp/BOYAmt0750000
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt013060553
IRS990/GrossReceiptsAmt024228841
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt07
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InvestmentInJointVentureInd01
IRS990/InvestmentsProgramRelatedGrp/BOYAmt011038170
IRS990/InvestmentsProgramRelatedGrp/EOYAmt021506962
IRS990/IRPDocumentCnt014
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0DE
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt02999959
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND'S MISSION IS TO ACCELERATE THE TRANSLATION OF RETINAL LABORATORY-BASED RESEARCH INTO CLINICAL TRIALS TO EXPEDITE THE COMMERCIALIZATION OF PATIENT THERAPIES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt010310777
IRS990/NetAssetsOrFundBalancesEOYAmt030604571
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt010060594
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt010060594
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt010310777
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt030604571
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ProgramServicesAmt014731
IRS990/OccupancyGrp/TotalAmt014731
IRS990/OfficeExpensesGrp/ProgramServicesAmt02134
IRS990/OfficeExpensesGrp/TotalAmt02134
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt00
IRS990/OtherAssetsTotalGrp/EOYAmt06101810
IRS990/OtherChangesInNetAssetsAmt01086879
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt048155
IRS990/OtherEmployeeBenefitsGrp/TotalAmt048155
IRS990/OtherExpensesGrp/Desc0SERVICE FEES TO FFB
IRS990/OtherExpensesGrp/Desc1PRINTING & PRODUCTION
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt021350
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1319
IRS990/OtherExpensesGrp/ProgramServicesAmt09150
IRS990/OtherExpensesGrp/ProgramServicesAmt13765
IRS990/OtherExpensesGrp/TotalAmt030500
IRS990/OtherExpensesGrp/TotalAmt14084
IRS990/OtherLiabilitiesGrp/BOYAmt0351055
IRS990/OtherLiabilitiesGrp/EOYAmt0351056
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt062514
IRS990/OtherSalariesAndWagesGrp/TotalAmt062514
IRS990/OwnWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt03312
IRS990/PayrollTaxesGrp/ProgramServicesAmt028462
IRS990/PayrollTaxesGrp/TotalAmt031774
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt023232
IRS990/PensionPlanContributionsGrp/TotalAmt023232
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt05000
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt02584
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt01757
IRS990/PrincipalOfficerNm0BENJAMIN YERXA
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0900099
IRS990/ProgramServiceRevenueGrp/Desc0MANAGEMENT FEES
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt027500
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt027500
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt011939089
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt02250000
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt0310951
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt08954687
IRS990/PYSalariesCompEmpBnftPaidAmt0423451
IRS990/PYTotalExpensesAmt02984402
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt011939089
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt019206915
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt011140788
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd01
IRS990/RevenueAmt027500
IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd01
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0DURING THE YEAR ENDED JUNE 30, 2021, FOUNDATION FIGHTING BLINDNESS RD FUND AWARDED GRANTS TO ORGANIZATIONS THAT COMPLETE RESEARCH THAT CONTRIBUTES TO THE CURE AND TREATMENT OF RETINAL DISEASES. THESE GRANTS ARE AWARDED AT THE DIRECTION OF THE SUPPORTED ORGANIZATION AND DIRECTLY RELATE TO THE SUPPORTED ORGANIZATION'S MISSION.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART IV, SECTION A, LINE 6:
IRS990ScheduleA/IRSWrittenDeterminationInd0X
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/SupportedOrganizationsCnt01
IRS990ScheduleA/SupportedOrganizationsTotalCnt01
IRS990ScheduleA/SupportedOrgInformationGrp/EIN0237135845
IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd01
IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd07
IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt011140788
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt0THE FOUNDATION FIGHTING BLINDNESS INC
IRS990ScheduleA/SupportingOrganization509a3Ind0X
IRS990ScheduleA/SupportingOrgType1Ind0X
IRS990ScheduleA/SupportSumAmt011140788
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/DonatedServicesAndUseFcltsAmt0196222
IRS990ScheduleD/DonatedServicesUseFcltsAmt0196222
IRS990ScheduleD/ExpensesNotReportedAmt040742591
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt011171288
IRS990ScheduleD/ExpensesSubtotalAmt0-9149321
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt07815949
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt1875000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt23358877
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt35749997
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt4249999
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt53000000
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt6457140
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc0SPARING VISION
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc1NAYAN THERAPEUTICS, INC.
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc2VEDERE BIO, INC.
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc3ATSENA THERAPEUTICS
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc4STARGAZER
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc5NACUITY
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc6LOOKOUT THERAPEUTICS, INC.
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd0F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd1F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd2F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd3F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd4F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd5F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd6F
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt05601810
IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt1500000
IRS990ScheduleD/OtherAssetsOrgGrp/Desc0DUE FROM RELATED PARTY
IRS990ScheduleD/OtherAssetsOrgGrp/Desc1DUE FROM RELATED PARTY
IRS990ScheduleD/OtherExpensesIncludedAmt040546369
IRS990ScheduleD/OtherExpensesNotIncludedAmt011171288
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt0351056
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0DUE TO RELATED PARTY
IRS990ScheduleD/OtherRevenueAmt030563269
IRS990ScheduleD/OtherRevenuesNotIncludedAmt011171288
IRS990ScheduleD/RevenueNotReportedAmt030759491
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt011171288
IRS990ScheduleD/RevenueSubtotalAmt010057594
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0THE FOUNDATION PERFORMED AN EVALUATION OF ITS UNCERTAINTY IN INCOME TAX FOR THE YEARS ENDED JUNE 30, 2021 AND 2020, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE CONSOLIDATED FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. THE FOUNDATION FOLLOWS THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES, WHICH ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS. UNDER THIS POLICY, THE FOUNDATION MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WOULD BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES, BASED ON THE TECHNICAL MERITS OF THE POSITION. MANAGEMENT HAS EVALUATED THE FOUNDATION'S TAX POSITIONS AND HAS CONCLUDED THAT THE FOUNDATION HAS TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH PROVISIONS OF THIS GUIDANCE. THE FOUNDATION IS NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS FOR THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS BEFORE JUNE 30, 2018.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt1REVENUE FROM AFFILIATE INCLUDED ON CONSOLIDATED FINANCIAL STATEMENTS 29,476,390. GAIN ON EQUITY METHOD INVESTMENTS 1,086,879.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt2ELIMINATION ENTRY INCLUDED ON FINANCIAL STATEMENTS 11,171,288.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt3EXPENSES FROM AFFILIATES INCLUDED ON CONSOLIDATED FINANCIAL STATEMENTS 40,546,369.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt4ELIMINATION ENTRY INCLUDED ON FINANCIAL STATEMENTS 11,171,288.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART X, LINE 2:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc1PART XI, LINE 2D - OTHER ADJUSTMENTS:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc2PART XI, LINE 4B - OTHER ADJUSTMENTS:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc3PART XII, LINE 2D - OTHER ADJUSTMENTS:
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc4PART XII, LINE 4B - OTHER ADJUSTMENTS:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt00
IRS990ScheduleD/TotalBookValueOtherAssetsAmt06101810
IRS990ScheduleD/TotalBookValueProgramRltdAmt021506962
IRS990ScheduleD/TotalExpensesPerForm990Amt02021967
IRS990ScheduleD/TotalLiabilityAmt0351056
IRS990ScheduleD/TotalRevenuePerForm990Amt021228882
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt040817085
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt031593270
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt10
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt01000000
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt17815949
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0EUROPE (INCLUDING ICELAND & GREENLAND)
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt1EUROPE (INCLUDING ICELAND & GREENLAND)
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0GRANTMAKING
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt1INVESTMENT
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Facts available. Structured filing facts are available, but richer extracted sections are limited.$59.6$0.10$59.5$7.01$2.44$4.57
2024Detailed filing. Detailed filing data is available for this year.$52.5$0.09$52.4$8.75$1.31$7.44
2023Detailed filing. Detailed filing data is available for this year.$47.3$0.07$47.2$9.32$1.01$8.30
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$45.4$0.42$44.9$15.4$1.05$14.4
2021Detailed filing. Detailed filing data is available for this year.$31.0$0.41$30.6$21.2$2.02$19.2
2020Detailed filing. Detailed filing data is available for this year.$11.4$1.13$10.3$11.9$2.98$8.95
2019Summary only. Only limited summary data is available for this year.$4.04$0.40$3.64$3.08$3.06$0.01
2018Detailed filing. Detailed filing data is available for this year.$3.89$0.68$3.21$13.3$11.8$1.45
2017Detailed filing. Detailed filing data is available for this year.$4.86$3.11$1.76$5.41$4.80$0.61
2016Detailed filing. Detailed filing data is available for this year.$2.71$1.62$1.09$3.69$3.49$0.20
2015Detailed filing. Detailed filing data is available for this year.$1.33$1.11$0.22$4.67$4.61$0.07
2014Detailed filing. Detailed filing data is available for this year.$2.94$2.78$0.16$4.74$5.14$0.40
2013Summary only. Only limited summary data is available for this year.$2.31$1.75$0.56$5.20$5.09$0.10
2012Summary only. Only limited summary data is available for this year.$1.77$1.31$0.46$2.87$3.64$0.77
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.38$1.15$1.23$3.16